The closely contested odds around 52.5% Yes for California Proposition 38 reflect voter weighing of potential advances in immunology and immunotherapy research for cancer, heart disease, and Alzheimer’s against the measure’s fiscal and structural features. The $8.4 billion general obligation bond would direct roughly half the funds to a single University of California-affiliated institute under narrow criteria, with the rest allocated via competitive grants, while requiring treatment price discounts and repayment from the state General Fund at an estimated $500 million annually for 25 years. Trader balance stems from support tied to research priorities amid federal funding pressures offset by scrutiny over concentrated allocation and long-term debt service. Recent polling trends, campaign spending disclosures, or shifts in state revenue projections could tip sentiment ahead of the November 3, 2026 vote.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourProposition d'obligation de recherche en immunologie en Californie
Oui
Oui
This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Marché ouvert : Jul 1, 2026, 6:33 PM ET
Resolver
0x65070BE91...This market will resolve to “Yes” if the specified ballot measure is approved by a majority of voters at the California statewide general election currently scheduled for November 3, 2026. Otherwise, this market will resolve to “No.”
If voting on the specified ballot measure does not occur, or the results thereof are not known definitively, by March 31, 2027, this market will resolve to “No”.
This market will resolve based on a consensus of credible reporting. If there is ambiguity, this market will resolve solely based on official information from the State of California, including the California Secretary of State (https://www.sos.ca.gov/).
Resolver
0x65070BE91...The closely contested odds around 52.5% Yes for California Proposition 38 reflect voter weighing of potential advances in immunology and immunotherapy research for cancer, heart disease, and Alzheimer’s against the measure’s fiscal and structural features. The $8.4 billion general obligation bond would direct roughly half the funds to a single University of California-affiliated institute under narrow criteria, with the rest allocated via competitive grants, while requiring treatment price discounts and repayment from the state General Fund at an estimated $500 million annually for 25 years. Trader balance stems from support tied to research priorities amid federal funding pressures offset by scrutiny over concentrated allocation and long-term debt service. Recent polling trends, campaign spending disclosures, or shifts in state revenue projections could tip sentiment ahead of the November 3, 2026 vote.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes